AuxoCell Laboratories has licensed its patented stem cell extraction process to Community Blood Services for use in the operation of the first Wharton's jelly-derived stem cell bank in the U.S. The bank will store "primitive, fetal mesenchymal stem cells from the gelatinous portion of donated umbilical cords, known as Wharton's Jelly" for research and treatment purposes, CBS said.

Full Story:
NJBIZ (New Jersey)

Related Summaries